Concepts (266)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Anal Canal | 3 | 2024 | 36 | 1.660 |
Why?
|
| Receptors, G-Protein-Coupled | 4 | 2024 | 127 | 1.470 |
Why?
|
| Muscle Contraction | 7 | 2024 | 202 | 1.410 |
Why?
|
| Muscle, Smooth | 7 | 2024 | 134 | 1.370 |
Why?
|
| Anoctamin-1 | 5 | 2024 | 16 | 1.350 |
Why?
|
| Myocytes, Smooth Muscle | 4 | 2024 | 60 | 1.080 |
Why?
|
| Taste | 2 | 2024 | 36 | 0.910 |
Why?
|
| Regeneration | 6 | 2017 | 95 | 0.880 |
Why?
|
| Taste Buds | 1 | 2024 | 4 | 0.870 |
Why?
|
| Calcium Signaling | 3 | 2021 | 158 | 0.810 |
Why?
|
| Bacillus subtilis | 3 | 2006 | 31 | 0.740 |
Why?
|
| Muscle Relaxation | 1 | 2021 | 32 | 0.690 |
Why?
|
| Gene Deletion | 2 | 2021 | 307 | 0.670 |
Why?
|
| Calcium | 4 | 2024 | 573 | 0.640 |
Why?
|
| Tendons | 3 | 2015 | 26 | 0.590 |
Why?
|
| Glycoside Hydrolases | 2 | 2008 | 5 | 0.550 |
Why?
|
| Osteoarthritis | 3 | 2016 | 140 | 0.540 |
Why?
|
| Tissue Engineering | 4 | 2017 | 143 | 0.500 |
Why?
|
| RNA, Small Interfering | 2 | 2013 | 908 | 0.490 |
Why?
|
| Animals | 23 | 2024 | 20647 | 0.470 |
Why?
|
| Mesenchymal Stem Cell Transplantation | 1 | 2015 | 37 | 0.460 |
Why?
|
| Cell- and Tissue-Based Therapy | 1 | 2015 | 39 | 0.460 |
Why?
|
| Mice | 14 | 2024 | 10838 | 0.450 |
Why?
|
| Patellar Ligament | 1 | 2013 | 6 | 0.410 |
Why?
|
| Decorin | 1 | 2013 | 3 | 0.410 |
Why?
|
| Lentivirus | 1 | 2013 | 66 | 0.390 |
Why?
|
| Achilles Tendon | 3 | 2017 | 7 | 0.390 |
Why?
|
| Tendon Injuries | 2 | 2014 | 18 | 0.390 |
Why?
|
| Uterine Contraction | 2 | 2024 | 10 | 0.380 |
Why?
|
| Collagen Type V | 1 | 2011 | 2 | 0.370 |
Why?
|
| Stem Cells | 4 | 2017 | 258 | 0.350 |
Why?
|
| Obstetric Labor, Premature | 2 | 2024 | 31 | 0.350 |
Why?
|
| Bacillus | 2 | 2008 | 13 | 0.330 |
Why?
|
| Signal Transduction | 5 | 2019 | 3030 | 0.330 |
Why?
|
| Spinal Cord Injuries | 3 | 2015 | 50 | 0.320 |
Why?
|
| Rats, Sprague-Dawley | 7 | 2017 | 622 | 0.300 |
Why?
|
| Calcium Channels | 2 | 2019 | 103 | 0.280 |
Why?
|
| Ryanodine Receptor Calcium Release Channel | 2 | 2019 | 44 | 0.280 |
Why?
|
| Protein Engineering | 1 | 2008 | 82 | 0.280 |
Why?
|
| Rats | 7 | 2017 | 1980 | 0.260 |
Why?
|
| Chondrocytes | 3 | 2016 | 42 | 0.250 |
Why?
|
| Basic Helix-Loop-Helix Transcription Factors | 3 | 2016 | 126 | 0.250 |
Why?
|
| Archaeal Proteins | 1 | 2005 | 6 | 0.240 |
Why?
|
| Archaea | 1 | 2005 | 9 | 0.240 |
Why?
|
| Cell Differentiation | 5 | 2017 | 1349 | 0.240 |
Why?
|
| Tissue Scaffolds | 2 | 2017 | 87 | 0.230 |
Why?
|
| Enzymes | 1 | 2005 | 35 | 0.230 |
Why?
|
| Biotechnology | 1 | 2005 | 43 | 0.230 |
Why?
|
| Gene Expression Regulation | 6 | 2019 | 1614 | 0.230 |
Why?
|
| Gene Expression Profiling | 3 | 2021 | 765 | 0.230 |
Why?
|
| Recombinant Fusion Proteins | 3 | 2015 | 495 | 0.220 |
Why?
|
| Calcinosis | 2 | 2016 | 83 | 0.220 |
Why?
|
| Peptides | 1 | 2008 | 577 | 0.220 |
Why?
|
| Genitalia | 1 | 2024 | 9 | 0.220 |
Why?
|
| Bacterial Proteins | 2 | 2008 | 768 | 0.220 |
Why?
|
| Semen | 1 | 2024 | 47 | 0.210 |
Why?
|
| Cartilage, Articular | 2 | 2014 | 76 | 0.200 |
Why?
|
| Homeodomain Proteins | 2 | 2015 | 266 | 0.200 |
Why?
|
| Wound Healing | 2 | 2014 | 189 | 0.200 |
Why?
|
| Base Sequence | 2 | 2021 | 1332 | 0.200 |
Why?
|
| Recombinant Proteins | 1 | 2004 | 700 | 0.190 |
Why?
|
| Myometrium | 2 | 2024 | 15 | 0.190 |
Why?
|
| Cell Lineage | 3 | 2017 | 267 | 0.180 |
Why?
|
| Methacholine Chloride | 1 | 2021 | 23 | 0.180 |
Why?
|
| Tongue | 1 | 2021 | 15 | 0.180 |
Why?
|
| Extracellular Matrix | 2 | 2013 | 139 | 0.180 |
Why?
|
| Reflex | 1 | 2021 | 27 | 0.180 |
Why?
|
| Respiratory System | 1 | 2021 | 44 | 0.170 |
Why?
|
| Mice, Knockout | 3 | 2021 | 2110 | 0.170 |
Why?
|
| Chloride Channels | 2 | 2019 | 28 | 0.160 |
Why?
|
| Nitric Oxide | 1 | 2021 | 174 | 0.160 |
Why?
|
| Humans | 20 | 2024 | 63163 | 0.160 |
Why?
|
| Ligands | 1 | 2021 | 416 | 0.160 |
Why?
|
| Muscle Tonus | 1 | 2019 | 3 | 0.160 |
Why?
|
| Urethra | 1 | 2019 | 71 | 0.150 |
Why?
|
| Viral Tropism | 1 | 2019 | 51 | 0.150 |
Why?
|
| Cytomegalovirus | 1 | 2019 | 91 | 0.150 |
Why?
|
| Tenocytes | 1 | 2017 | 1 | 0.140 |
Why?
|
| Multiprotein Complexes | 1 | 2019 | 153 | 0.140 |
Why?
|
| Proto-Oncogene Proteins c-fos | 1 | 2017 | 52 | 0.140 |
Why?
|
| Silk | 1 | 2017 | 7 | 0.140 |
Why?
|
| Bronchial Hyperreactivity | 1 | 2017 | 25 | 0.140 |
Why?
|
| Xylans | 2 | 2008 | 5 | 0.140 |
Why?
|
| Sulfonic Acids | 1 | 2017 | 8 | 0.140 |
Why?
|
| Gelatin | 1 | 2017 | 29 | 0.140 |
Why?
|
| Chitosan | 2 | 2015 | 85 | 0.130 |
Why?
|
| Printing, Three-Dimensional | 1 | 2017 | 38 | 0.130 |
Why?
|
| Paracrine Communication | 1 | 2017 | 15 | 0.130 |
Why?
|
| Viral Proteins | 1 | 2019 | 261 | 0.130 |
Why?
|
| Muscle Cells | 1 | 2017 | 28 | 0.130 |
Why?
|
| Cells, Cultured | 4 | 2017 | 2153 | 0.130 |
Why?
|
| ADAM Proteins | 2 | 2014 | 32 | 0.130 |
Why?
|
| Enzyme Stability | 2 | 2008 | 46 | 0.130 |
Why?
|
| beta-Glucans | 2 | 2008 | 56 | 0.130 |
Why?
|
| Respiratory Mucosa | 1 | 2017 | 53 | 0.130 |
Why?
|
| Epithelial Cells | 1 | 2019 | 390 | 0.130 |
Why?
|
| Myosin-Light-Chain Kinase | 1 | 2016 | 11 | 0.130 |
Why?
|
| Therapy, Soft Tissue | 1 | 2016 | 1 | 0.130 |
Why?
|
| Muscle Hypotonia | 1 | 2016 | 7 | 0.130 |
Why?
|
| Cell Cycle Checkpoints | 1 | 2016 | 47 | 0.130 |
Why?
|
| Cell Separation | 1 | 2016 | 147 | 0.130 |
Why?
|
| Calcium Channels, L-Type | 1 | 2016 | 26 | 0.130 |
Why?
|
| Cartilage | 1 | 2016 | 34 | 0.130 |
Why?
|
| Doxorubicin | 1 | 2016 | 99 | 0.120 |
Why?
|
| Fecal Incontinence | 1 | 2016 | 31 | 0.120 |
Why?
|
| Molecular Sequence Data | 3 | 2009 | 1997 | 0.120 |
Why?
|
| Cellular Senescence | 1 | 2016 | 110 | 0.120 |
Why?
|
| Fingolimod Hydrochloride | 1 | 2015 | 2 | 0.120 |
Why?
|
| Temperature | 2 | 2008 | 307 | 0.120 |
Why?
|
| Sphingosine | 1 | 2015 | 20 | 0.120 |
Why?
|
| Gliosis | 1 | 2015 | 28 | 0.120 |
Why?
|
| Kinetics | 2 | 2008 | 761 | 0.120 |
Why?
|
| Lysophospholipids | 1 | 2015 | 27 | 0.120 |
Why?
|
| Transforming Growth Factor beta2 | 1 | 2015 | 8 | 0.120 |
Why?
|
| Injections, Intra-Articular | 1 | 2015 | 51 | 0.120 |
Why?
|
| Coculture Techniques | 1 | 2015 | 96 | 0.120 |
Why?
|
| Polyesters | 1 | 2015 | 48 | 0.120 |
Why?
|
| Organogenesis | 1 | 2015 | 39 | 0.110 |
Why?
|
| Fibroblasts | 1 | 2016 | 387 | 0.110 |
Why?
|
| Cell Proliferation | 3 | 2016 | 980 | 0.110 |
Why?
|
| Polyglycolic Acid | 1 | 2014 | 18 | 0.110 |
Why?
|
| Piperidines | 1 | 2014 | 63 | 0.110 |
Why?
|
| rac1 GTP-Binding Protein | 1 | 2013 | 17 | 0.110 |
Why?
|
| Aminoquinolines | 1 | 2013 | 16 | 0.110 |
Why?
|
| Arthritis, Experimental | 1 | 2013 | 29 | 0.110 |
Why?
|
| Lactic Acid | 1 | 2014 | 76 | 0.110 |
Why?
|
| Hydrogel, Polyethylene Glycol Dimethacrylate | 1 | 2014 | 32 | 0.110 |
Why?
|
| Flavonoids | 1 | 2014 | 75 | 0.110 |
Why?
|
| Stem Cell Transplantation | 1 | 2013 | 79 | 0.100 |
Why?
|
| Induced Pluripotent Stem Cells | 1 | 2015 | 147 | 0.100 |
Why?
|
| Astrocytes | 1 | 2014 | 119 | 0.100 |
Why?
|
| Neuropeptides | 1 | 2013 | 82 | 0.100 |
Why?
|
| Hyaluronic Acid | 1 | 2014 | 67 | 0.100 |
Why?
|
| Protease Inhibitors | 1 | 2014 | 102 | 0.100 |
Why?
|
| Inflammation Mediators | 1 | 2014 | 176 | 0.100 |
Why?
|
| Pyrimidines | 1 | 2013 | 135 | 0.100 |
Why?
|
| Asthma | 1 | 2017 | 440 | 0.100 |
Why?
|
| Graft Survival | 1 | 2013 | 290 | 0.100 |
Why?
|
| Extracellular Matrix Proteins | 1 | 2013 | 35 | 0.100 |
Why?
|
| Estradiol | 1 | 2013 | 257 | 0.100 |
Why?
|
| Escherichia coli | 2 | 2008 | 700 | 0.100 |
Why?
|
| Collagen | 1 | 2013 | 127 | 0.100 |
Why?
|
| Tumor Necrosis Factor-alpha | 1 | 2015 | 614 | 0.090 |
Why?
|
| Models, Animal | 1 | 2013 | 236 | 0.090 |
Why?
|
| Cell Culture Techniques | 1 | 2013 | 182 | 0.090 |
Why?
|
| Collagen Type III | 1 | 2011 | 4 | 0.090 |
Why?
|
| Collagen Type I | 1 | 2011 | 41 | 0.090 |
Why?
|
| Phenanthrolines | 2 | 2024 | 10 | 0.090 |
Why?
|
| Adipose Tissue | 1 | 2013 | 296 | 0.090 |
Why?
|
| Transfection | 1 | 2013 | 691 | 0.090 |
Why?
|
| Female | 9 | 2024 | 32720 | 0.090 |
Why?
|
| Protein Isoforms | 1 | 2011 | 198 | 0.090 |
Why?
|
| Immunity, Innate | 1 | 2017 | 796 | 0.090 |
Why?
|
| Oxytocin | 2 | 2024 | 45 | 0.090 |
Why?
|
| Apoptosis | 2 | 2013 | 1073 | 0.080 |
Why?
|
| Adhesins, Escherichia coli | 1 | 2009 | 3 | 0.080 |
Why?
|
| Lactococcus lactis | 1 | 2009 | 8 | 0.080 |
Why?
|
| Escherichia coli Vaccines | 1 | 2009 | 11 | 0.080 |
Why?
|
| Enterotoxigenic Escherichia coli | 1 | 2009 | 22 | 0.080 |
Why?
|
| Pregnancy | 3 | 2024 | 2324 | 0.080 |
Why?
|
| Recovery of Function | 3 | 2015 | 286 | 0.070 |
Why?
|
| Escherichia coli Infections | 1 | 2009 | 87 | 0.070 |
Why?
|
| Osteoarthritis, Knee | 1 | 2013 | 385 | 0.070 |
Why?
|
| Nanoparticles | 1 | 2014 | 518 | 0.070 |
Why?
|
| RNA, Messenger | 1 | 2013 | 1536 | 0.070 |
Why?
|
| Disease Models, Animal | 1 | 2015 | 2187 | 0.070 |
Why?
|
| Artificial Gene Fusion | 1 | 2006 | 5 | 0.070 |
Why?
|
| Chromatography | 1 | 2006 | 16 | 0.060 |
Why?
|
| ATP-Binding Cassette Transporters | 1 | 2006 | 37 | 0.060 |
Why?
|
| Chondrogenesis | 2 | 2016 | 9 | 0.060 |
Why?
|
| Signal Recognition Particle | 1 | 2006 | 39 | 0.060 |
Why?
|
| Metabolic Networks and Pathways | 1 | 2006 | 87 | 0.060 |
Why?
|
| Cloning, Molecular | 1 | 2006 | 383 | 0.060 |
Why?
|
| Protein Transport | 1 | 2006 | 401 | 0.060 |
Why?
|
| Gene Expression | 1 | 2008 | 838 | 0.060 |
Why?
|
| Enzyme Activation | 1 | 2005 | 380 | 0.060 |
Why?
|
| Structure-Activity Relationship | 1 | 2005 | 371 | 0.050 |
Why?
|
| Endothelin-1 | 1 | 2024 | 7 | 0.050 |
Why?
|
| 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid | 1 | 2024 | 7 | 0.050 |
Why?
|
| Dinoprost | 1 | 2024 | 19 | 0.050 |
Why?
|
| Delayed-Action Preparations | 2 | 2015 | 114 | 0.050 |
Why?
|
| Protein Folding | 1 | 2004 | 266 | 0.050 |
Why?
|
| Protein Conformation | 1 | 2005 | 777 | 0.050 |
Why?
|
| Mice, Transgenic | 2 | 2016 | 1278 | 0.050 |
Why?
|
| Cell Line | 2 | 2017 | 2036 | 0.050 |
Why?
|
| Transcription, Genetic | 1 | 2004 | 878 | 0.040 |
Why?
|
| Litter Size | 1 | 2019 | 10 | 0.040 |
Why?
|
| Potassium Chloride | 1 | 2019 | 15 | 0.040 |
Why?
|
| Infant, Newborn | 1 | 2024 | 1354 | 0.040 |
Why?
|
| A549 Cells | 1 | 2019 | 39 | 0.040 |
Why?
|
| Urinary Incontinence, Stress | 1 | 2019 | 29 | 0.040 |
Why?
|
| Real-Time Polymerase Chain Reaction | 1 | 2019 | 208 | 0.040 |
Why?
|
| Cyclic AMP-Dependent Protein Kinases | 1 | 2019 | 93 | 0.040 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2019 | 543 | 0.040 |
Why?
|
| Male | 5 | 2017 | 29722 | 0.040 |
Why?
|
| Proto-Oncogene Proteins c-akt | 1 | 2019 | 203 | 0.040 |
Why?
|
| Electrophysiological Phenomena | 1 | 2017 | 21 | 0.030 |
Why?
|
| HeLa Cells | 1 | 2019 | 535 | 0.030 |
Why?
|
| Fibroblast Growth Factor 2 | 1 | 2017 | 16 | 0.030 |
Why?
|
| Transducin | 1 | 2017 | 7 | 0.030 |
Why?
|
| Magnesium Sulfate | 1 | 2017 | 9 | 0.030 |
Why?
|
| Dermis | 1 | 2017 | 18 | 0.030 |
Why?
|
| Guinea Pigs | 1 | 2017 | 84 | 0.030 |
Why?
|
| Skin Physiological Phenomena | 1 | 2017 | 16 | 0.030 |
Why?
|
| Albuterol | 1 | 2017 | 24 | 0.030 |
Why?
|
| Epidermis | 1 | 2017 | 36 | 0.030 |
Why?
|
| Chloroquine | 1 | 2017 | 61 | 0.030 |
Why?
|
| Quaternary Ammonium Compounds | 1 | 2017 | 29 | 0.030 |
Why?
|
| HEK293 Cells | 1 | 2019 | 618 | 0.030 |
Why?
|
| Neovascularization, Physiologic | 1 | 2017 | 104 | 0.030 |
Why?
|
| Niflumic Acid | 1 | 2016 | 3 | 0.030 |
Why?
|
| Bethanechol | 1 | 2016 | 4 | 0.030 |
Why?
|
| Nifedipine | 1 | 2016 | 19 | 0.030 |
Why?
|
| Defecation | 1 | 2016 | 17 | 0.030 |
Why?
|
| Digoxin | 1 | 2016 | 22 | 0.030 |
Why?
|
| Cellular Microenvironment | 1 | 2016 | 21 | 0.030 |
Why?
|
| Patch-Clamp Techniques | 1 | 2016 | 130 | 0.030 |
Why?
|
| Rheumatic Heart Disease | 1 | 2016 | 22 | 0.030 |
Why?
|
| Biocompatible Materials | 1 | 2017 | 149 | 0.030 |
Why?
|
| Membrane Potentials | 1 | 2016 | 141 | 0.030 |
Why?
|
| Administration, Topical | 1 | 2015 | 51 | 0.030 |
Why?
|
| Membranes, Artificial | 1 | 2015 | 45 | 0.030 |
Why?
|
| Tendinopathy | 1 | 2015 | 10 | 0.030 |
Why?
|
| Databases, Genetic | 1 | 2015 | 89 | 0.030 |
Why?
|
| SOX9 Transcription Factor | 1 | 2014 | 7 | 0.030 |
Why?
|
| DNA Damage | 1 | 2016 | 280 | 0.030 |
Why?
|
| Early Growth Response Protein 2 | 1 | 2014 | 8 | 0.030 |
Why?
|
| Early Growth Response Protein 1 | 1 | 2014 | 15 | 0.030 |
Why?
|
| Glial Fibrillary Acidic Protein | 1 | 2014 | 40 | 0.030 |
Why?
|
| Skin | 1 | 2017 | 373 | 0.030 |
Why?
|
| Surface Properties | 1 | 2015 | 278 | 0.030 |
Why?
|
| Eyelids | 1 | 2013 | 8 | 0.030 |
Why?
|
| ADAMTS5 Protein | 1 | 2013 | 1 | 0.030 |
Why?
|
| Matrix Metalloproteinase 13 | 1 | 2013 | 7 | 0.030 |
Why?
|
| Aggrecans | 1 | 2014 | 8 | 0.030 |
Why?
|
| Hypertrophy | 1 | 2013 | 30 | 0.030 |
Why?
|
| Stress, Mechanical | 1 | 2014 | 112 | 0.030 |
Why?
|
| Hydrogen Peroxide | 1 | 2013 | 77 | 0.030 |
Why?
|
| Fibroblast Growth Factors | 1 | 2014 | 72 | 0.030 |
Why?
|
| Microspheres | 1 | 2013 | 56 | 0.030 |
Why?
|
| Microtubule-Associated Proteins | 1 | 2014 | 115 | 0.030 |
Why?
|
| Treatment Outcome | 2 | 2015 | 5621 | 0.030 |
Why?
|
| Phenotype | 1 | 2017 | 1199 | 0.030 |
Why?
|
| Transplantation, Heterologous | 1 | 2013 | 229 | 0.030 |
Why?
|
| Athletic Injuries | 1 | 2014 | 83 | 0.030 |
Why?
|
| Immunosuppressive Agents | 1 | 2015 | 377 | 0.030 |
Why?
|
| Core Binding Factor Alpha 1 Subunit | 1 | 2013 | 142 | 0.030 |
Why?
|
| Intercellular Signaling Peptides and Proteins | 1 | 2013 | 151 | 0.020 |
Why?
|
| Proteolysis | 1 | 2014 | 145 | 0.020 |
Why?
|
| Interleukin-1beta | 1 | 2014 | 264 | 0.020 |
Why?
|
| Behavior, Animal | 1 | 2014 | 230 | 0.020 |
Why?
|
| Biomarkers | 1 | 2017 | 1392 | 0.020 |
Why?
|
| Cell Cycle Proteins | 1 | 2014 | 394 | 0.020 |
Why?
|
| Drug Delivery Systems | 1 | 2014 | 327 | 0.020 |
Why?
|
| Mice, Inbred ICR | 1 | 2009 | 32 | 0.020 |
Why?
|
| Mice, Inbred C57BL | 1 | 2016 | 3394 | 0.020 |
Why?
|
| Neurons | 1 | 2014 | 923 | 0.020 |
Why?
|
| Antibodies, Bacterial | 1 | 2009 | 194 | 0.020 |
Why?
|
| Administration, Oral | 1 | 2009 | 369 | 0.020 |
Why?
|
| Survival Analysis | 1 | 2009 | 579 | 0.020 |
Why?
|
| DNA, Bacterial | 1 | 2009 | 266 | 0.020 |
Why?
|
| Sequence Analysis, DNA | 1 | 2009 | 414 | 0.020 |
Why?
|
| Inflammation | 1 | 2014 | 1145 | 0.020 |
Why?
|
| Immunoglobulin G | 1 | 2009 | 468 | 0.020 |
Why?
|
| Aged | 1 | 2016 | 14328 | 0.010 |
Why?
|
| Middle Aged | 1 | 2016 | 17472 | 0.010 |
Why?
|